Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nestle Health Science to acquire Prometheus
Nestle Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or the special challenges of different life stages. With this acquisition,
Nestle Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or the special challenges of different life stages. With this acquisition,
Under the agreement, Valeant will acquire 87.2% of the outstanding shares of Sanitas, with at least 82.6% of the outstanding shares required to be delivered at closing. Sanitas
Edict Pharma is an India-based developer and manufacturer of solid oral dosage generic pharmaceuticals. With this acquisition, Par expects to strengthen its R&D business and enhance its manufacturing
Nitrofurantoin oral suspension is an anti-bacterial medication indicated for the treatment of urinary tract infection. Amneal’s Nitrofurantoin oral suspension is generic version and therapeutically equivalent alternative to Furadantin
Under the licensing pact, the new company will take over the development and commercialization of Lilly‘s severe sepsis treatment, Xigris (drotrecogin alfa (activated)), in the US. Additionally, BioCritica
eCareSoft’s solution is an ONC-ATCB certified complete inpatient EHR solution designed to help small to mid-size hospital groups achieve American Recovery and Reinvestment Act (ARRA) ‘meaningful use’ stimulus
Oralair, a sublingual grass pollen immunotherapy tablet, has demonstrated efficacy in seven placebo controlled clinical trials involving more than 2,500 patients. Earlier in 2007, Stallergenes has licensed Canadian
Elekta‘s integrated Oncology Information Systems features a complete, patient-centric chart optimized for medical oncology, radiation oncology and comprehensive practices. Elekta claims MOSAIQ’s single-database EHR can perform clinical decision
The study recruited around 579 patients and has evaluated the efficacy and tolerability of various doses of CRTH2 antagonist in adult patients who were suffering from seasonal allergic
The CHMP positive opinion is based on three pivotal, Phase 3 head-to-head trials that evaluated the effectiveness of XGEVA versus Zometa (zoledronic acid) at delaying skeletal-related events (SREs).